Plunkett Research Online: Cymabay Therapeutics Inc

CYMABAY THERAPEUTICS INC (CBAY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and .....


CYMABAY THERAPEUTICS INC

Ticker: CBAY
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 510 293-8800
Fax: 510 293-9090
Address: 7999 Gateway Boulevard
Newark, CA 94560 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Sujal ShahCEO/Director/President
Harish ShantharamCFO
See More
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture